Amanda M. Olson
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Applied Psychology top 10%
- Behavioral Health and Interventions
Papers in
-
- DNA Repair Mechanisms 5
- Cancer therapeutics and mechanisms 3
- Protein Degradation and Inhibitors 2
- Oncology 13
- PARP inhibition in cancer therapy 9
- Cancer-related Molecular Pathways 4
- Co-authors
- Eric F. Johnson (9 shared papers)Cherrie K. Donawho (7 shared papers)Yan Shi (6 shared papers)Donald J. Osterling (11 shared papers)Jennifer J. Bouska (10 shared papers)David Maag (4 shared papers)Enrico L. DiGiammarino (3 shared papers)Todd A. Hopkins (3 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Molecular Cancer Research (2 papers)ACS Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Amanda M. Olson
22 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 106
- Oncology 611
- Applied Psychology 77
- Organic Chemistry 235
- Molecular Biology 506
- Reproductive Medicine 48
Countries citing papers authored by Amanda M. Olson
This map shows the geographic impact of Amanda M. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda M. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda M. Olson more than expected).
Fields of papers citing papers by Amanda M. Olson
This network shows the impact of papers produced by Amanda M. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda M. Olson. The network helps show where Amanda M. Olson may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda M. Olson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 215 | |
| 2 | 2015 | 198 | |
| 3 | 2018 | 173 | |
| 4 | 2001 | 135 | |
| 5 | 2009 | 99 | |
| 6 | 2009 | 91 | |
| 7 | 2007 | 31 | |
| 8 | 2004 | 31 | |
| 9 | 2017 | 24 | |
| 10 | 2012 | 24 | |
| 11 | 2012 | 19 | |
| 12 | 2014 | 18 | |
| 13 | 2017 | 17 | |
| 14 | 2012 | 12 | |
| 15 | 2006 | 11 | |
| 16 | 2020 | 10 | |
| 17 | Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide | 2005 | 6 |
| 18 | 2007 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2014 | 4 |
About Amanda M. Olson
Amanda M. Olson is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Electrical and Electronic Engineering, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (9 papers), DNA Repair Mechanisms (5 papers), Cancer-related Molecular Pathways (4 papers), Cancer therapeutics and mechanisms (3 papers), Microtubule and mitosis dynamics (3 papers), Protein Degradation and Inhibitors (2 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Integrated Circuits and Semiconductor Failure Analysis (2 papers). The work is most often cited by research in Oncology (611 citations), Applied Psychology (77 citations), Organic Chemistry (235 citations), Molecular Biology (506 citations) and Reproductive Medicine (48 citations). Amanda M. Olson has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Eric F. Johnson, Cherrie K. Donawho, Yan Shi, Donald J. Osterling, Jennifer J. Bouska, David Maag, Enrico L. DiGiammarino, Todd A. Hopkins, Sanjay C. Panchal and Julie L. Wilsbacher. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecular Cancer Research, ACS Medicinal Chemistry Letters, Journal of Medicinal Chemistry and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.